Cite Score:
0.65
ELSEVIER SCOPUS

Acute Hepatitis B in a Patient with Antibody to Hepatitis B Surface Antigen who was Receiving Chemotherapy for Acute Myelogenous Leukemia with Cytarabine and Daunorubicin

AUTHORS

Mehdi Dehghani 1 , *

AUTHORS INFORMATION

1 Assistant Professor, Section of Hematology and Oncology, Department of Internal Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

ARTICLE INFORMATION

Shiraz E-Medical Journal: 9 (1); 42-44
Published Online: January 1, 2008
Article Type: Case Report
Received: May 1, 2005
Accepted: September 2, 2007

Crossmark

CHEKING

READ FULL TEXT
Abstract

Hepatitis B virus asymptomatic carriers should receive treatment in certain conditions, such as prior to chemotherapy and organ transplantation. In these groups interferon alpha has limited efficacy or is even contraindicated. In contrast, lamivudine is highly effective in both preventing of and treat- ment of HBV reactivation in these immunosuppressed patients. Prevention of reactivation has better results than treating reactivation.

Keywords

Acute Hepatitis B, Acute Leukemia, Immunosuppression.

© 2008, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Full Text

Full text is available in PDF

COMMENTS

LEAVE A COMMENT HERE: